Skip to content

Oric Pharmaceuticals, Inc. ORIC Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$2.56M+61.0%
CG Oncology logo
CG OncologyCGON
$8.07M+1,377%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$2.6M-373%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$1.06M+246%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.59M+192%
Septerna, Inc. logo
Septerna, Inc.SEPN
$294K-39.8%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets?
Oric Pharmaceuticals, Inc. (ORIC) reported increase (decrease) in prepaid expense and other assets of $679K in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Oric Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets increased by 18.1% year-over-year, from $575K to $679K.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets?
Over 2 years (2022 to 2025), Oric Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a 31.7% compound annual growth rate (CAGR), from -$1.03M to -$1.79M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.